DJ Amgen Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. $(AMGN)$ shed 1.32% to $280.10 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.83% to 6,502.08 and the Dow Jones Industrial Average rising 0.77% to 45,621.29.
This was the stock's third consecutive day of losses.
Amgen Inc. closed 17.42% below its 52-week high of $339.17, which the company achieved on September 23rd.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.43% to $178.76, Pfizer Inc. $(PFE)$ fell 1.01% to $24.54, and AbbVie Inc. $(ABBV)$ rose 0.54% to $213.00.
Trading volume (2.6 M) eclipsed its 50-day average volume of 2.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
September 04, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.